Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis - PubMed (original) (raw)
Comparative Study
Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis
R B Low et al. Am Rev Respir Dis. 1992 Sep.
Abstract
Collagen deposition is a prime determinant of clinical course in idiopathic pulmonary fibrosis (IPF). Identification of a marker of connective tissue metabolism would significantly enhance the ability to stage the disease and monitor the course of these patients. Prior studies of IPF have indicated that N-terminal Type III procollagen peptide (N-PIIIP) levels in blood and bronchoalveolar lavage BAL fluid are elevated. We hypothesized that elevated levels of procollagen peptides are a marker of enhanced collagen deposition, which is associated with interstitial fibrosis characterizing active disease. The purpose of the present study was to explore the relationship between N-PIIIP recovery and physiologic parameters of lung function. N-PIIIP levels in sera and bronchoalveolar lavage (BAL) from 24 patients with IPF and 29 volunteers were measured by radioimmunoassay. The extent of disease in IPF was assessed by clinical history, physical examination, chest radiograph, pulmonary physiology evaluation, and confirmatory open-lung biopsy. The severity of disease was graded using a previously described clinical, radiologic, and physiologic (CRP) scoring system. N-PIIIP normalized to albumin was higher in BAL than in serum for both volunteers (1.6-fold; p less than 0.05) and IPF patients (24-fold; p less than 0.05), consistent with local pulmonary production. BAL N-PIIIP was significantly elevated in IPF patients, whether expressed as concentration (healthy volunteer 0.11 +/- 0.06 ng/ml; IPF, 5.0 +/- 14.4; mean +/- SD; p less than 0.05) or normalized to albumin (healthy volunteer, 2.8 +/- 1.2; IPF, 73 +/- 106; p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
Cantin AM, Boileau R, Bégin R. Cantin AM, et al. Am Rev Respir Dis. 1988 Mar;137(3):572-8. doi: 10.1164/ajrccm/137.3.572. Am Rev Respir Dis. 1988. PMID: 3345038 - Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis.
Behr J, Maier K, Krombach F, Adelmann-Grill BC. Behr J, et al. Am Rev Respir Dis. 1991 Jul;144(1):146-50. doi: 10.1164/ajrccm/144.1.146. Am Rev Respir Dis. 1991. PMID: 2064121 - Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis.
Low RB, Cutroneo KR, Davis GS, Giancola MS. Low RB, et al. Lab Invest. 1983 Jun;48(6):755-9. Lab Invest. 1983. PMID: 6855198 - [PROGNOSTIC VALUE OF BLOOD AND BRONCHOALVEOLAR LAVAGE FLUIDS BIOMARKERS FOR IDIOPATHIC PULMONARY FYBROSIS (REVIEW)].
Yakovleva О, Klekot А, Shcherbeniuk N, Hoina-Kardasevich O. Yakovleva О, et al. Georgian Med News. 2019 Sep;(294):98-103. Georgian Med News. 2019. PMID: 31687958 Review. Russian.
Cited by
- Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.
Schins RP, Lamers RJ, Préat B, Borm PJ. Schins RP, et al. Int Arch Occup Environ Health. 1995;66(6):413-9. doi: 10.1007/BF00383149. Int Arch Occup Environ Health. 1995. PMID: 7782126 - Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome.
Forel JM, Guervilly C, Farnarier C, Donati SY, Hraiech S, Persico N, Allardet-Servent J, Coiffard B, Gainnier M, Loundou A, Sylvestre A, Roch A, Bourenne J, Papazian L. Forel JM, et al. PLoS One. 2018 Nov 5;13(11):e0206105. doi: 10.1371/journal.pone.0206105. eCollection 2018. PLoS One. 2018. PMID: 30395619 Free PMC article. - Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects.
Park MY, Bae S, Heo JA, Park M, Kim Y, Han J, Jang IJ, Yu KS, Oh J. Park MY, et al. Clin Transl Sci. 2023 Jul;16(7):1163-1176. doi: 10.1111/cts.13518. Epub 2023 Apr 24. Clin Transl Sci. 2023. PMID: 37095713 Free PMC article. Clinical Trial. - Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
Mostafa AI, Salem AE, Ahmed HAM, Bayoumi AI, Halim RMA, Samie RMA. Mostafa AI, et al. Tuberc Respir Dis (Seoul). 2021 Jul;84(3):200-208. doi: 10.4046/trd.2020.0122. Epub 2021 Apr 6. Tuberc Respir Dis (Seoul). 2021. PMID: 33840176 Free PMC article. - Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.
Forel JM, Guervilly C, Hraiech S, Voillet F, Thomas G, Somma C, Secq V, Farnarier C, Payan MJ, Donati SY, Perrin G, Trousse D, Dizier S, Chiche L, Baumstarck K, Roch A, Papazian L. Forel JM, et al. Intensive Care Med. 2015 Jan;41(1):1-11. doi: 10.1007/s00134-014-3524-0. Epub 2014 Oct 30. Intensive Care Med. 2015. PMID: 25354475
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous